Hos patienter med akut trombotisk sygdom kan både den gradvist voksende stigning i protein C plasma niveauer såvel som halveringstiden reduceres betragteligt.
In patients with acute thrombotic disease, both the incremental increase in protein C plasma levels as well as half-life may be considerably reduced.